Abstract
Chronic stress induces changes in the prefrontal cortex and hippocampus. Selenium nanoparticles (SeNPs) showed promising results in several neurological animal models. The implementation of SeNPs in chronic restraint stress (CRS) remains to be elucidated. This study was done to determine the possible protective effects of selenium nanoparticles on behavioral changes and brain oxidative stress markers in a rat model of CRS. 50 rats were divided into three groups; control group (n = 10), untreated CRS group (n = 10) and CRS-SeNPs treated group (n = 30). Restraint stress was performed 6 h./day for 21 days. Rats of CRS-SeNPs treated group received 1, 2.5 or 5 mg/kg SeNPs (10 rats each) by oral gavage for 21 days. Rats were subjected to behavioral assessments and then sacrificed for biochemical and histological analysis of the prefrontal cortex and hippocampus. Prefrontal cortical and hippocampal serotonin levels, oxidative stress markers including malondialdehyde (MDA), reduced glutathione (GSH) and glutathione peroxidase (GPx), tumor necrosis factor alpha (TNF-α) and caspase-3 were assessed. Accordingly, different doses of SeNPs showed variable effectiveness in ameliorating disease parameters, with 2.5 mg/kg dose of SeNPs showing the best improving results in all studied parameters. The present study exhibited the neuroprotective role of SeNPs in rats subjected to CRS and proposed their antioxidant, anti-inflammatory and anti-apoptotic effects as the possible mechanism for increased prefrontal cortical and hippocampal serotonin level, ameliorated anxiety-like and depressive-like behaviors and improved prefrontal cortical and hippocampal histological architecture.
Similar content being viewed by others
Avoid common mistakes on your manuscript.
Introduction
Recently, mankind is experiencing different sets of circumstances that lead to diverse types of stress. Stress is the adverse stimuli boosting a negative impact on the body homeostasis, with the resultant physiological and psychological responses [1, 2]. Physiological responses to stress occur via activation of sympatho-adrenomedullary (SAM) axis and hypothalamic pituitary adreno-cortical (HPA) axis. SAM axis comprises the rapid, immediate response to stress in which there is release of epinephrine and norepinephrine from the adrenal medulla and release of norepinephrine from the sympathetic nerves [3, 4]. HPA axis comprises the slower, prolonged response to stress in which there is release of corticotropin-releasing hormone (CRH) from the hypothalamus. CRH induces adrenocorticotropic hormone (ACTH) production from the anterior pituitary gland. Then, ACTH stimulates glucocorticoids secretion from the adrenal cortex [3].
Exposure to chronic stress results in overactivation of HPA axis. This leads to sustained elevation in the glucocorticoids level, which induces structural and functional changes in the brain, specifically the prefrontal cortex and hippocampus. These regions regulate behavior and emotions, and process psychogenic stress [5]. Oxidative stress is the imbalance between reactive oxygen species (ROS) production and antioxidant defense systems [6]. The brain is highly susceptible to oxidative stress, due to its high oxygen consumption, high lipid content and low antioxidant levels [7]. It was reported that neuronal oxidative stress develops as a consequence of chronic psychological stress, with its resultant DNA damage, lipid peroxidation and alterations in proteins functioning [8]. It was evidenced that chronic psychological stress results in activation of brain microglia that release large quantities of pro-inflammatory cytokines, such as tumor necrosis factor-alpha (TNF-α) [9]. Chronic stress is capable of upregulating the expression of pro-apoptotic proteins, such as caspase-3 [10]. In chronic psychological stress, release of neurotransmitters that regulate mood and behavior, such as serotonin is greatly diminished [11]. Animal models of chronic stress enabled better understanding of its effects on brain morphology and functioning. Chronic restraint stress (CRS) model is utilized in preclinical studies to demonstrate the effects of chronic psychological stress [12]. It leads to behavioral alterations that resemble day to day stressors that are repeated and piled up on the previous day’s workload [13].
Nowadays, nanomedicine field is gaining popularity for enabling the implementation of nanostructures in diagnosing, preventing and treating various diseases [14]. Nanomaterials have small sizes that vary between 1 and 100 nm, and high surface area to volume ratio. Therefore, nano-based drug delivery systems provide better absorption, bioavailability and stability than other known drug delivery systems [15]. Selenium nanoparticles are a subject of interest in nanomedicine for multiple reasons. First, they have higher uptake by the cells than selenium when taken orally as they are absorbed by endocytosis [14]. Second, they exhibit better antioxidant activity than any other chemical forms of selenium. They also have higher bioavailability than selenium due to the possibility of utilizing selenium in the zero-oxidation state (Se0) [16]. Third, they are far less toxic than selenium [17]. The possible neuroprotective effects of selenium nanoparticles in chronic stress remains to be elucidated.
Material and Methods
Experimental Animals
The study was carried out on 50 adult male Wistar rats aged 8–10 weeks, with a body weight ranging from 200–250 g. The animals were kept under standard laboratory conditions, maintained on a 12-h light–dark cycle with free access to food and water at the animal house of Physiology Department. All experimental procedures were conducted according to the NIH Guide for Care and Use of Laboratory Animals and followed the ARRIVE guidelines. The study protocol was approved by the institutional Medical Ethics Committee, Faculty of Medicine (IRB NO: 00012098; FWA NO: 00018699; approval NO: 0106414).
Preparation of Selenium Nanoparticles (SeNPs)
Selenium nanoparticles were synthetized by polyethylene glycol (PEG)-200 according to Nie et al., 2016 with minor modifications. 170 mg selenium powder was added in 200 mL PEG-200 solution containing 0.1M glucose at 100°C for 20 min until the complete formation of the nanoparticles, under magnetic stirring. Glucose was used as a reducing agent, while polyethylene glycol acted as a surface decorator of selenium nanoparticles to enhance their stability [18].
To study shape and size of SeNPs, transmission electron microscopy (TEM; JEOL-JSM 1400 Plus, Tokyo, Japan) was done. Samples were prepared by placing a drop of the nanosuspension on paraffin sheet. Then, carbon coated grid was placed on the sample and left for 1 min to allow nanoparticles to adhere on the carbon substrate. The remaining suspension was removed and samples were air dried before microscopic examination [19]. Furthermore, particle size distribution, polydispersity index (PDI) and zeta potential of the dispersion were determined by dynamic light scattering (DLS) technique using Zetasizer Nano ZS. (Malvern, Instruments Ltd., Malvern, UK).
Experimental Groups and Tissue Sampling
After 7 days of adaptation, rats were divided into 3 groups as follows: control group (n = 10) in which rats received 1.5 ml distilled water daily by oral gavage for 21 days as a vehicle and were not exposed to chronic restraint stress; untreated chronic restraint stress (CRS) group (n = 10) in which rats were exposed to chronic restraint stress. Each rat was placed inside a small and narrow device in order to restrict its movement [20]. This device was in the form of a plastic bottle, whose dimensions were 21 (height) × 7 (diameter) cm. This was done daily over a period of 6 h. for 21 days from 9.00 am to 3.00 pm. These plastic bottles kept the rats well-contained with very limited movements and had holes to allow sufficient breathing [2]. During the restraint stress period, rats were deprived of food and water [21]. At the same time, each rat in this group also received 1.5 ml distilled water by oral gavage daily as a vehicle 15 min before the restraint stress period; CRS- SeNPs treated group (n = 30) which was subdivided into 3 subgroups (10 rats each) in which rats received different doses of SeNPs (1 mg/kg, 2.5 mg/kg or 5 mg/kg SeNPs) dissolved in 1.5 ml distilled water by oral gavage daily 15 min before the restraint stress period for 21 days [22]. Body weights of all rats were recorded at days 7, 14 and 21 of the study. Behavioral tests were conducted after day 21 of the study for 4 consecutive days. At day 26 of the study, rats were sacrificed by decapitation under ether anesthesia. The whole brain was removed immediately and rinsed in ice cold saline. The prefrontal cortical and hippocampal tissues were quickly dissected and stored at -80 °C until they were homogenized in the appropriate buffer for biochemical analysis. Prefrontal cortical and hippocampal tissue specimens from all studied groups were processed for histopathological examination. Another specimen of the prefrontal cortical and hippocampal tissues from the SeNPs-treated subgroups was assigned for transmission electron microscopic examination (TEM; JEOL-JSM 1400 Plus, Tokyo, Japan) to confirm the uptake of SeNPs (Fig. 1).
Behavioral Tests
Behavioral tests were performed between 9.00 am and 5.00 pm, and were recorded and analyzed by an observer who was blind to the experimental groups.
-
1.
Elevated plus maze test
This test was performed at day 22 of the study to evaluate anxiety-like behavior of rats. The maze consisted of two open arms perpendicular to two closed arms and a small central square between the arms. The maze was elevated 70 cm above the floor. Each rat was placed individually at the center of the maze with its head facing towards the open arm and was allowed to explore it freely for 5 min. Number of entries in closed arms, number of entries in open arms, time spent in closed arms and time spent in open arms were recorded. After each rat trial, the arena was cleaned with 70% ethyl alcohol [23].
-
2.
Open field test
This test was performed at day 23 of the study to evaluate the locomotor activity and anxiety-like behavior of rats. The arena consisted of an open wooden box, whose dimensions were 75 (length) × 75 (width) × 35 (height) cm and its floor was divided into 16 squares. Each rat was placed individually at the center of the arena and was allowed to explore it freely for 5 min. Number of squares crossed and number of rears were recorded. After each rat trial, the arena was cleaned with 70% ethyl alcohol [24].
-
3.
Forced swim test
This test was performed at day 24 of the study to evaluate behavioral despair. Rats were placed in an open plastic container, whose dimensions were 50 (height) × 40 (diameter) cm and was filled up to 40 cm of its height with water at 25 ± 1°C. Rats were trained to swim for 15 min. Twenty-four hours later, they were forced to swim again for 5 min. During this 5-min period, the immobility time was recorded. The rat was considered immobile if it was floating passively with only minor movements to keep its head above the water. After each trial, rats were dried with a towel and returned to their cages [25].
-
4.
Sucrose preference test
This test was performed at day 25 of the study to evaluate anhedonia [26]. Anhedonia is defined as diminished capability to experience pleasure and it is a core symptom of depressive behavior [27]. This test required training. Each rat was placed alone in a small cage. In the first 24 h., each rat was presented with two bottles; both containing 100 ml of 2% sucrose solution. In the following 24 h., each rat was also presented with two bottles; one containing 100 ml of 2% sucrose solution and the other containing 100 ml of tap water. After training, rats were deprived of water for 16 h. Later on, the test was done where each rat was presented with a bottle containing 100 ml of 2% sucrose solution and another containing 100 ml of tap water for 4 h. After 2 h., the position of the bottles was changed to avoid side preference. After the 4 h. duration, the bottles were weighed and percentage of sucrose preference was calculated using the following formula: (sucrose solution consumption/sucrose solution consumption + water consumption) X 100 [28].
Brain Distribution of SeNPs
Prefrontal cortical and hippocampal tissue specimens were first cut into (0.5–1 mm) cubes and were immediately fixed in 4% formaldehyde/1% glutaraldehyde. These cubes were post-fixed in 1% osmium tetroxide, rinsed in phosphate buffer for 1–2 h, dehydrated with graded ethanol, embedded in plastic capsules of araldite, polymerized, and processed to get semithin sections. The semithin sections were cut, stained with methylene blue and localized using a light microscope. Ultrathin sections were stained with uranyl acetate and lead citrate [29].
Prefrontal Cortical and Hippocampal Tissues Neurobiochemical Assays
-
1.
Determination of serotonin by high performance liquid chromatography (HPLC)
For that purpose, prefrontal cortical and hippocampal tissues were homogenized in ice cold methanol (4 ml/g tissue). Then, 1 ml of the homogenate was centrifuged at 14,000 rpm for 20 min. The supernatant was left to be evaporated to dryness by vacuum freeze. The dry residue was reconstituted with 300 µl de-ionized water and mixed with the vortex for 10 s. Afterwards, 300 µl solution of chloroform: isopropanol (100:30, v/v) was added and mixed with the vortex for 2 min. Then, it was centrifuged at 3000 rpm for 5 min. The upper aqueous layer was separated and injected into HPLC system [30]. For chromatographic separation, an HPLC Agilent 1100 chromatography system was used. Chromatographic separation was achieved on a Zorbax SB C18 chromatography column (4.6 × 250 mm, 5 µm). The mobile phase consisted of acetate buffer (pH 3.5, 12 mM acetic acid, 0.26 mM Na2EDTA)–methanol (86:14, v/v). The fluorescence was monitored at excitation and emission wavelengths of 279 nm and 320 nm, respectively. Peaks were recognized by comparing their retention time in the tissue sample extract solution with that of standard solution. The results were normalized to tissue weight to be expressed as ng/mg tissue [31].
-
2.
Measurement of markers of oxidative stress state
Prefrontal cortical and hippocampal tissues were homogenized in 10 times (w/v) ice cold 0.1 M phosphate buffer (pH 7.4) containing protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA) and centrifuged at 10,000 xg at 4°C for 15 min [19]. The quantitative measurement of the lipid peroxidation marker, malondialdehyde (MDA), reduced glutathione (GSH) and glutathione peroxidase (GPx) activity was performed by colorimetric assay according to the instructions provided by the kit (Sigma-Aldrich, St. Louis, MO, USA). MDA results were normalized to tissue weight to be expressed in nmol/g tissue while GSH results were normalized to tissue weight to be expressed in mg/g tissue. Finally, GPx activity results were normalized to tissue weight to be expressed in U/g tissue.
-
3.
Measurement of tumor necrosis factor alpha (TNF-α) and caspase-3 by ELISA
Prefrontal cortical and hippocampal tissues were homogenized in 10 times (w/v) ice cold 0.1 M phosphate buffer (pH 7.4) containing protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO, USA) and centrifuged at 10,000 xg at 4°C for 15 min [19]. With the aim of normalization of tissue biochemical results, aliquots of tissue homogenate supernatant were analyzed in duplicate for total protein concentration. The Bio-Rad protein assay kit protocol (Bio-Rad, Mississauga, Canada) was adopted for the determination of lysate protein concentration. The quantitative measurement of the inflammatory marker, TNF-α, (Sigma-Aldrich, St. Louis, MO, USA) and apoptotic marker, caspase-3 (Bio Vision, MA, USA) was done using sandwich ELISA kits according to the manufacturer’s instructions. Tissue results were normalized to total tissue proteins to be expressed as ng/mg protein for TNF-α and pg/mg protein for caspase-3.
Histopathological Examination
Prefrontal cortical and hippocampal tissue specimens were fixed in 10% buffered formol-saline and processed to get paraffin blocks that were sectioned at 5 µm thick coronal sections, deparaffinized and stained with hematoxylin and eosin (H&E) for histological analysis using light microscopy [32].
Statistical Analysis
Data were collected and analyzed using SPSS Statistics for Windows (25.0; SPSS Inc., Chicago, IL, USA). Distributions of quantitative variables were tested for normality using Shapiro–Wilk test. If it revealed normal data distribution, parametric tests were applied. If the data were abnormally distributed, non-parametric tests were used. Normally distributed data were expressed as mean and standard deviation. They were analyzed using F-test (one- way ANOVA), followed when significant by Post Hoc test (Tukey) for pair-wise comparisons. Abnormally distributed data were expressed as median and interquartile range. Kruskal Wallis test was used to compare between different groups and pair wise comparison was assessed using Mann–Whitney U test. All tests were two tailed and p < 0.05 was considered statistically significant. Graphs were prepared using GraphPad Prism (version 8.0 for Windows).
Results
Characterization of the Synthesized SeNPs
Transmission electron microscope showed that SeNPs were monodispersed spheres, with a size ranging between 20 to 30 nm (Fig. 2a). Dynamic light scattering (DLS) showed a 100% peak at a size of 92.01 nm (Fig. 2b), with a PDI of 0.435. Zeta potential was -30.5 mV (Fig. 2c) and this marks good stability.
Transmission Electron Microscopic Examination of Prefrontal Cortex and Hippocampus of Rats of SeNPs-treated Group
Transmission electron microscopic examination confirmed prefrontal cortical and hippocampal uptake of the different doses of SeNPs used in the present study. Clusters of electron dense SeNPs were seen within the nuclei and the lysosomes of the neuronal perikarya with a size ranging between 20 to 30 nm (Fig. 3a-e).
Effect of SeNPs on Body Weight
The untreated CRS group did not show any significant change in the body weight of rats at days 7, 14 and 21 of the study, compared to the control group. Treatment of rats with 1 and 2.5 mg/kg SeNPs exhibited a significant reduction in the mean body weight at days 7, 14 and 21 of the study, compared to the control group (Fig. 4a-c). Rats treated with 1 mg/kg SeNPs had a significantly lower body weight at day 14, compared to the untreated CRS rats (Fig. 4b). In addition, rats treated with 2.5 mg/kg SeNPs showed a significant loss of body weight at days 7 and 14, compared with the untreated CRS rats (Fig. 4a-b). Rats treated with 5 mg/kg of SeNPs had no significant difference in the body weight at days 7, 14 and 21 of the study, compared to the control group and untreated CRS group (Fig. 4a-c).
Effect of SeNPs on Behavioral Tests
-
1.
Elevated plus maze test
There was no significant difference between the untreated CRS group and the control group regarding number of entries in closed arms and time spent in closed arms (Fig. 5a-b). However, the number of entries in open arms and the time spent in open arms were significantly decreased in the untreated CRS group, versus the control group (Fig. 5c-d).
Treatment of rats with 2.5 mg/kg of SeNPs significantly increased the number of entries in closed arms and decreased the time spent in closed arms versus control group and untreated CRS group. Rats treated with 1 mg/kg of SeNPs did not show significant difference in the number of entries and the time spent in closed arms versus control group and untreated CRS group. Rats treated with 5 mg/kg of SeNPs exhibited significant decrease in the time spent in closed arms versus untreated CRS rats and no significant difference in the number of entries in closed arms versus control group and untreated CRS group (Fig. 5a-b).
The 2.5 and 5 mg/kg doses of SeNPs showed significant rise in the number of entries in open arms and time spent in open arms compared to untreated CRS rats, and caused significantly higher number of entries in open arms than the control group. However, the 1 mg/kg dose of SeNPs did not show significant difference in the number of entries in open arms and time spent in open arms compared to untreated CRS group (Fig. 5c-d).
-
2.
Open field test
Untreated CRS rats showed decreased locomotor activity and anxiety-like behavior, which was evident by significant reduction in both number of squares crossed and number of rears versus the control group. Significant improvement was observed in rats treated with 2.5 mg/kg of SeNPs, where both number of squares crossed and number of rears were significantly increased versus untreated CRS rats. On the contrary, there was no significant improvement observed with rats treated with 1 mg/kg and 5 mg/kg doses of SeNPs compared to untreated CRS rats (Fig. 5e-f).
-
3.
Forced swim test
The immobility time was significantly increased in untreated CRS rats, compared to the control group, indicating behavioral despair. Rats treated with 2.5 mg/kg and 5 mg/kg of SeNPs showed a significant decrease in the immobility time compared to untreated CRS rats. On the other hand, the 1 mg/kg of SeNPs did not show any significant difference in the immobility time compared with untreated CRS group (Fig. 5g).
-
4.
Sucrose preference test
The percentage of sucrose preference in the untreated CRS group was significantly decreased compared with the control group, thus indicating anhedonia. Treatment of rats with all three doses of SeNPs significantly increased the percentage of sucrose preference versus untreated CRS group (Fig. 5h).
Effect of SeNPs on Neurobiochemical Tests
-
1.
Prefrontal cortical and hippocampal serotonin
Untreated CRS rats showed a significant reduction in the prefrontal cortical tissue levels of serotonin versus the control group. However, treatment of rats with 2.5 mg/kg and 5 mg/kg of SeNPs significantly raised the prefrontal cortical tissue level of serotonin compared to untreated CRS rats. Rats treated with 1 mg/kg of SeNPs did not significantly improve serotonin level compared to untreated CRS rats (Fig. 6a).
In the hippocampal tissues of untreated CRS rats, there was a significant decrease in serotonin level versus the control group. Rats treated with 2.5 mg/kg of SeNPs showed significant rise in serotonin level compared to untreated CRS rats. On the other hand, treatment of rats with either 1 mg/kg or 5 mg/kg of SeNPs did not significantly improve serotonin level compared to untreated CRS rats (Fig. 6b).
-
2.
Oxidative stress markers
In the prefrontal cortical tissues of untreated CRS rats, there was a significant increase in MDA levels versus control group, indicating lipid peroxidation. Rats treated with 2.5 mg/kg of SeNPs had a significant reduction in the prefrontal cortical tissue level of MDA versus untreated CRS rats. However, treatment of rats with either 1 mg/kg or 5 mg/kg of SeNPs did not significantly decrease MDA levels compared to untreated CRS group (Fig. 7a). In the hippocampal tissues of untreated CRS rats, there was a significant elevation in MDA level, compared to the control group, indicating lipid peroxidation. Treatment with all three doses of SeNPs significantly reduced the MDA levels compared to untreated CRS rats (Fig. 7b).
In the prefrontal cortical tissue of untreated CRS rats, there was a significant reduction in GSH levels versus the control group. Treatment of rats with 2.5 mg/kg of SeNPs caused a significant rise in the prefrontal cortical tissue level of GSH versus untreated CRS rats. On the contrary, treatment of rats with either 1 mg/kg or 5 mg/kg of SeNPs did not result in significant elevation in the GSH levels compared to untreated CRS group (Fig. 7c). Regarding the hippocampal tissue levels of GSH, it was significantly decreased in untreated CRS rats versus the control group. Rats treated with 2.5 mg/kg of SeNPs exhibited a significant rise in GSH level versus untreated CRS rats. However, rats treated with 1 mg/kg and 5 mg/kg doses of SeNPs did not cause significant elevation in the GSH levels compared to untreated CRS group (Fig. 7d).
Untreated CRS rats showed a significant reduction in glutathione peroxidase activity in the prefrontal cortical tissue, compared to the control group. Rats treated with 2.5 mg/kg and 5 mg/kg of SeNPs showed a significant improvement in glutathione peroxidase activity in the prefrontal cortical tissue compared to untreated CRS rats. On the other hand, rats treated with 1 mg/kg of SeNPs did not exhibit any significant improvement compared to untreated CRS group (Fig. 7e). In the hippocampal tissues of untreated CRS rats, there was a significant reduction in glutathione peroxidase activity, versus the control group. Treatment of rats with 2.5 mg/kg and 5 mg/kg of SeNPs caused a significant elevation in glutathione peroxidase activity versus untreated CRS rats. On the other hand, rats treated with 1 mg/kg of SeNPs did not cause any significant improvement versus untreated CRS group (Fig. 7f).
-
3.
Prefrontal cortical and hippocampal tumor necrosis factor-alpha (TNF-α)
In untreated CRS rats, there was a significant increase in the prefrontal cortical tissue levels of TNF-α versus the control group, indicating neuroinflammation. Rats treated with 1 mg/kg and 2.5 mg/kg of SeNPs showed a significant reduction in the prefrontal cortical tissue level of TNF-α versus untreated CRS group. On the contrary, rats treated with 5 mg/kg of SeNPs did not significantly improve the TNF-α levels compared to untreated CRS rats (Fig. 8a).
Regarding the hippocampal tissue levels of TNF-α, it was significantly increased in untreated CRS rats versus the control group, indicating neuroinflammation. Treatment with 2.5 mg/kg and 5 mg/kg of SeNPs caused a significant decrease in TNF-α level versus untreated CRS group. However, treatment with 1 mg/kg of SeNPs did not significantly improve the TNF-α levels compared to untreated CRS group (Fig. 8b).
-
4.
Prefrontal cortical and hippocampal caspase-3
Untreated CRS rats showed a significant increase in the prefrontal cortical tissue levels of caspase-3 versus the control group, indicating apoptosis. Treatment of rats with 2.5 mg/kg of SeNPs significantly decreased the prefrontal cortical tissue level of caspase-3 versus untreated CRS rats. However, treatment of rats with either 1 mg/kg or 5 mg/kg of SeNPs did not significantly improve caspase-3 levels compared to untreated CRS rats (Fig. 8c).
Regarding the hippocampal tissues, untreated CRS rats showed a significant elevation in caspase-3 level, compared to the control group, indicating apoptosis. Treatment of rats with 2.5 mg/kg of SeNPs significantly reduced caspase-3 level versus untreated CRS group. On the other hand, treatment of rats with either 1 mg/kg or 5 mg/kg of SeNPs did not significantly improve caspase-3 levels compared to untreated CRS group (Fig. 8d).
Effect of SeNPs on Histopathological Examination
-
1.
Light microscopic examination of prefrontal cortices
In control rats, examination of prefrontal cortex showed normal laminated appearance with six different layers of variable thickness. The layers were from superficial to deep; the molecular layer, beneath the pia mater, composed mainly of fibers and few nerves cell bodies; the external and internal granular layers showed the same architecture, they were formed of small, densely packed stellate neurons (granule cells); the external pyramidal layer consisted of small and medium-sized pyramidal neurons. The internal pyramidal layer was characterized by the prominent large and medium-sized pyramidal neurons, that have triangular cell bodies and large euchromatic nuclei. The deepest cortical layer, the polymorphic cell layer composed of loosely arranged cells of varying shapes and sizes. Deeper to it, the white matter was seen as regularly arranged bundles of nerve fibers separated by rows of neuroglia. The cortical neuropil was revealed as amorphous pale eosinophilic background among neuroglia and neuronal cell bodies (Fig. 9a-b).
In untreated CRS rats, the prefrontal cortical sections exhibited various degrees of degenerative changes that involved the neuronal cell layers and the white matter. Irregularity of the cortical surface was observed. The well-defined laminated pattern was almost lost with evident neuronal loss. Many neurons in different cortical layers appeared distorted, compared to those of control sections. They were surrounded by a lightly-stained spongy-like neuropil with many mouth-eaten small and large vacuoles. Occasional pyknotic nuclei of neurons were seen. The white matter showed several vacuoles between the disorganized bundles of nerve fibers (Fig. 9c-d).
In rats treated with 1 mg/kg SeNPs, the prefrontal cortical sections almost resembled those of the untreated CRS group except that the cortical surface was almost regular and the cortical neurons in various layers showed their normal morphology and laminar pattern. Manifestations of localized spongy-like neuropil were revealed with few vacuoles and sporadic mouth-eaten areas (Fig. 10a-b).
In rats treated with 2.5 mg/kg SeNPs, the prefrontal cortical sections showed that the appearance of prefrontal cortex was almost comparable to the control sections. Normal laminar pattern was revealed with prominent pyramidal cell layers. The smooth cortical surface was seen with nearly normal appearance of the neuropil. Normal arrangement of nerve fiber bundles of the white matter with nuclei of neuroglia was seen in between. Occasionally few vacuoles were depicted; however, they were small and localized (Fig. 10c-d).
In rats treated with 5 mg/kg SeNPs, examination of prefrontal cortex of rats revealed irregularity of the cortical surface with congested large blood vessels of the subarachnoid space. Disorganization of most cortical layers was depicted. Vacuolar necrotic areas were seen containing structureless fibrillar material (Fig. 11a-b).
-
2.
Light microscopic examination of the hippocampi
In control rats, examination of hippocampus showed normal architecture of hippocampus proper (cornu-ammonis). Three distinct layers were revealed; the innermost molecular cell layer containing nerve cell processes and few neurons. A middle pyramidal cell layer containing rows of hippocampal pyramidal cells with large euchromatic nuclei and triangular cell bodies. The outer polymorphic layer was also revealed. Fimbria showed properly arranged nerve fiber bundles separated by blood capillaries and rows of neuroglia (Fig. 12a-d).
In untreated CRS rats, the hippocampal sections exhibited disorganization of the pyramidal cell layer of hippocampus proper with evident neuronal loss. Many apoptotic pyramidal neurons appeared with shrunken cell bodies, hyper eosinophilic cytoplasm and pyknotic nuclei. Some vacuoles were seen in the polymorphic layer. Areas of dissolution of the white matter in fimbria were also revealed with breakup of its nerve fiber bundles, accompanied by vacuolation. Limited areas of cellular infiltration were seen (Fig. 13a-c).
In rats treated with 1 mg/kg and 2.5 mg/kg doses of SeNPs, examination of hippocampal sections gave similar histological results. They almost exhibited the normal organization of hippocampus proper and fimbria with evident increased vascularity in the form of numerous capillaries and large-sized blood vessels. The pyramidal cell layer of hippocampus proper depicted relative hypercellularity with variable-sized neurons extending into the polymorphic layer. Sporadic apoptotic pyramidal neurons were seen with shrunken cell bodies, hyper eosinophilic cytoplasm and pyknotic nuclei (Fig. 14a-b).
In rats treated with 5 mg/kg SeNPs, examination of hippocampus revealed no apparent increased vascularity. Areas of neuronal loss with decreased thickness of the pyramidal cell layer of hippocampus proper were depicted. Some neurons appeared with dark shrunken cell bodies. The fimbria was apparently normal (Fig. 15a-b).
Discussion
In the present study, we examined the protective effects of different doses of SeNPs on the body weight, neurobehavioral scores, biochemical and histological parameters of the prefrontal cortex and hippocampus in a model of CRS in rats. Treatment with different doses of SeNPs demonstrated variable effectiveness in ameliorating these changes, with the 2.5 mg/kg dose showing the best improving results in all studied parameters. To the best of our knowledge, this is the first study to explore the potential protective role of SeNPs in CRS.
Our study proved the uptake of different doses of SeNPs by the neurons of the prefrontal cortex and hippocampus using TEM. Characterization of SeNPs revealed that their size ranged from 20–30 nm, which contributed to the ability of SeNPs to cross the blood brain barrier. In addition, the glucose coating used while synthesizing SeNPs allowed their delivery into the neurons through interacting with the glucose transporters present in the membrane of the endothelial cells of the blood brain barrier.
Regarding body weight, CRS did not cause any change in body weight of rats on days 7, 14 and 21 of the present study compared to the control group. However, previous studies reported decrease in body weight of rats exposed to CRS in comparison to control rats [33,34,35,36,37,38,39,40,41,42,43,44,45,46,47,48]. Such contradiction between our study and other studies could be because the 21-day stress paradigm used in our study could not cause profound hypothalamic damage that may become evident with longer stress durations. Furthermore, Wistar rats used in our study may differ in their response to food intake and body weight when exposed to CRS with other rat strains, such as Sprague–Dawley rats which were also used in some of the previous studies. Only the rats treated with 1 mg/kg and 2.5 mg/kg doses of SeNPs showed significant reduction in the body weight at days 7, 14 and 21 of the study, versus the control group. Al-Quraishy et al. also found that SeNPs reduced body weight in streptozotocin-induced diabetic rats and denoted such finding to the ability of SeNPs to decrease food intake [49]. It was reported that selenoproteins can increase hypothalamic response to leptin and accordingly reduce food intake [50].
The present study showed that CRS induced oxidative stress through increasing MDA level and decreasing the level of reduced glutathione and glutathione peroxidase activity in the prefrontal cortical and hippocampal tissues versus control. These were supported by Ning et al. [21], Grundmann et al. [46], Fontella et al. [51] and Lin et al. [52]. This most likely occurred because chronic stress led to excessive production of glucocorticoids, which bind to their receptors in the prefrontal cortex and hippocampus inducing oxidative stress state by two mechanisms. The first one is through increasing mitochondrial oxidative phosphorylation, which in turn increased ROS generation and lipid peroxidation. The second one is abolishing the antioxidant defense response through decreasing the level of endogenous antioxidants [53]. In addition, CRS resulted in neuroinflammation and apoptosis and this was evidenced by elevating the levels of prefrontal cortical and hippocampal TNF-α and caspase-3 versus control. Jangra et al. [23], Banagozoar Mohammadi et al. [54], Novaes et al. [55], Pezeshki-Nia et al. [56], and Nouri et al. [57] supported CRS-induced neuroinflammation. While Kuswati [58], Orlovsky et al. [59] and Seo et al. [60] supported CRS-induced neuronal apoptosis. CRS-induced neuroinflammation could be explained by brain microglial activation, which led to increased production of pro-inflammatory cytokines. The high level of glucocorticoids released during chronic stress directly activates microglia of the prefrontal cortex and hippocampus since they express both glucocorticoid receptor and mineralocorticoid receptor. Chronic stress was also evidenced to cause peripheral low grade-inflammation due to the development of a state of glucocorticoid resistance, which eventually decreases the number of glucocorticoid receptors in the cytoplasm and downregulates glucocorticoid receptor driven anti-inflammatory genes. This causes the immune cells in the periphery to secrete large quantities of pro-inflammatory markers into the circulation, which cross the blood brain barrier and activate microglia. Furthermore, the pro-inflammatory cytokines directly stimulate HPA axis [61, 62]. Moreover, the brain oxidative stress state leads to dysregulation of the signaling pathways that modulate the immunological response within the CNS, with resultant upregulation of signaling pathways and transcription factors, such as phosphoinositide 3-kinase (PI3K)/Akt, MAPK and NF-κB, which eventually promote pro-inflammation [63, 64]. CRS-induced neuronal apoptosis could be explained by the activation of both intrinsic and extrinsic apoptotic pathways because of neuronal oxidative stress and neuroinflammation [65]. Chronic stress-induced glucocorticoids secretion was also shown to increase pro-apoptotic BAX protein expression and decrease anti-apoptotic Bcl-2 expression. As a result, BAX becomes inserted into the mitochondrial membrane leading to the release of cytochrome C, which binds the apoptotic activating factor-1 in the cytoplasm forming apoptosome. Then, the apoptosome activates caspase-9, which in turn activates caspase-3 [58, 66]. On the other hand, the 2.5 mg/kg dose of SeNPs was highly effective in preventing the neuronal oxidative stress, neuroinflammation and apoptosis induced by CRS. Previous studies noted the mitigating effect of SeNPs on the brain oxidative stress both in vivo [67,68,69,70,71,72,73] and in vitro [74, 75]. About 25 selenoproteins are expressed in the brain and they are abundant in the hippocampus and cerebral cortex [76]. SeNPs exert their antioxidant activity through incorporation into selenoproteins. Some of these selenoproteins are enzymes, known as selenoenzymes, that are needed for scavenging ROS. Of these selenoenzymes is the glutathione peroxidase, which removes the hydrogen peroxides by oxidizing glutathione [17]. Glutathione peroxidase isoenzyme 1 (GPX 1) and isoenzyme 4 (GPX4) are present at high levels in the brain [76]. SeNPs increase both the level and activity of these selenoenzymes. They have been shown to eradicate several ROS, such as superoxide anion, 1,1-diphenyl-2-picrylhydrazyl, singlet oxygen and carbon-centered free radicals [77]. Many studies demonstrated the alleviating effect of SeNPs on neuroinflammation [68, 70, 71]. The anti-inflammatory action of SeNPs can be explained by their ability to downregulate inflammatory transcription factors, such as NF-κB and MAPK and their signaling pathways [17], thus inhibiting microglial release of pro-inflammatory cytokines. In addition, selenoprotein S (SELENOS), selenoprotein K (SELENOK), selenoprotein P (SELENOP) and selenoprotein R (SELENOR) are involved in the regulation of neuroinflammation through decreasing the release of proinflammatory cytokines from microglia, increasing phagocytosis of microglia and decreasing microglial proliferation. Thus, SeNPs can exert their anti-inflammatory action through upregulation of these selenoproteins [76]. Yuan et al. [70] and Bashir et al. [67] also agreed with the anti-apoptotic activity of SeNPs on neurons through denoting their ability to elevate Bcl-2 expression and lower BAX expression. Accordingly, SeNPs can deactivate apoptotic pathways through their antioxidant and anti-inflammatory effects.
Our study also noted decreased prefrontal cortical and hippocampal serotonin levels in the untreated CRS group versus the control group. Similar results were obtained by Wang et al. [78], Aboul-Fotouh [34], Liang et al. [35] and Sunanda et al. [79]. This can be attributed to the reduced firing rate of the serotonergic neurons that occur as a result of the excessive generation of glucocorticoids by chronic stress. Several research studies also showed that chronic stress causes the downregulation of 5-hydroxytryptamine 1A (5-HT1A) receptor in both prefrontal cortex and hippocampus [80]. In addition, neuroinflammation was reported to induce tryptophan metabolism through the kynurenine pathway by the enzyme indoleamine-2,3-dioxygenase. Consequently, this lowers the influx of tryptophan into the brain, hence decreasing serotonin synthesis [81, 82]. Moreover, increased ROS generation renders the enzyme tryptophan hydroxylase in an oxidizing state that in turn deactivates its catalytic function and thus, serotonin synthesis is abolished [83]. Treatment with the 2.5 mg/kg dose of SeNPs significantly attenuated the decrease in both prefrontal cortical and hippocampal serotonin levels versus untreated CRS group. Al Kahtani [72] and Abou Zaid et al. [84] also noted elevated brain serotonin levels by SeNPs in rat models of cadmium and acrylamide-induced neurotoxicity respectively. They supported such finding by the antioxidant capacity of SeNPs. Thus, our study proposes that anti-inflammatory and anti-apoptotic actions of SeNPs, in addition to their antioxidant activity, to be the explanation for the restored levels of prefrontal cortical and hippocampal serotonin.
Regarding the behavioral tests, CRS induced anxiety-like behavior, through reducing number of entries in the open arms and less time spent in open arms in the elevated plus maze test and decreasing number of rears in the open field test versus control group. CRS also induced depressive-like behavior by increasing immobility time in the forced swim test and decreasing percentage of sucrose consumption in the sucrose preference test versus control group. In addition, CRS decreased locomotor activity through decreasing number of squares crossed in the open field test, compared to the control group. Peng et al. [44], Luo et al. [43], Bagheri et al. [39], Zhu et al. [85], Carneiro de Oliveira et al. [86], Nade et al. [20], Sheng et al. [87], Shen et al. [88] and Lee et al. [89] reported similar results. These neurobehavioral changes could be explained by the decreased prefrontal cortical and hippocampal serotonin levels [35]. Also, increased prefrontal cortical and hippocampal oxidative stress, TNF-α levels and caspase-3 levels depicted in our study upon exposure to chronic stress definitely contribute to these behavioral alterations [54]. SeNPs treatment significantly alleviated anxiety-like and depressive-like behaviors, specifically the 2.5 mg/kg dose, versus untreated CRS group. Ebokaiwe et al. [69] and Khalil et al. [90] reported improvement of several neurobehavioral parameters by SeNPs in rat models of streptozotocin-induced diabetes and deltamethrin-induced neurotoxicity respectively. Thus, SeNPs improved the neurobehavioral indices through restoring the prefrontal cortical and hippocampal serotonin levels, their antioxidant, anti-inflammatory and anti-apoptotic actions.
In the histological assessment, CRS exhibited evident neuronal loss and appearance of apoptotic pyramidal neurons with pyknotic nuclei in the prefrontal cortex and hippocampus. Such findings were supported by Salama et al. [91], Jayakumar et al. [92], Feng et al. [93], Chandrasekhar et al. [94], Becerril-Chavez et al. [1] and de Lima et al. [95]. They can be explained by the occurrence of reactive gliosis in the prefrontal cortex and hippocampus in response to neuroinflammation [95], which is evidenced by high prefrontal cortical and hippocampal TNF-α levels in our study. Also, elevated level of prefrontal cortical and hippocampal caspase-3 contributes to these findings. We also noted that the damage depicted by CRS in the prefrontal cortex was far more extensive and profound than that in the hippocampus. This may be supported by the prefrontal cortex being a highly organized structure [96], while the hippocampus is considered as a primitive cortical tissue [97]. Thus, on the structural level, the prefrontal cortical tissue is more sensitive to chronic stress than the hippocampal tissue. Only the 2.5 mg/kg dose of SeNPs was able to restore the normal architecture of the prefrontal cortex. Both 1 mg/kg and 2.5 mg/kg doses of SeNPs preserved the normal organization of the hippocampus through inducing hypervascularity and relative hypercellularity in the pyramidal cell layer. Abozaid noted that SeNPs slightly increased vascularity of the hippocampus proper in rat model of acrylamide-induced neurotoxicity [98]. Ibrahim et al. illustrated that SeNPs increased thickness of pyramidal cell layer of hippocampus proper in rat model of cyclophosphamide-induced neurotoxicity [99]. This histological improvement exhibited with SeNPs can be explained by their antioxidant, anti-inflammatory and anti-apoptotic activities depicted in our study. Hypervascularity and hypercellularity seen in the hippocampus and not in the prefrontal cortex can be interpreted by the ability of hippocampus to recover much better than the prefrontal cortex, since the CRS-induced hippocampal damage was less severe than that of prefrontal cortex.
In the present study, it is obvious that the effects of SeNPs were dose-dependent with rats treated with the 2.5 mg/kg dose exhibiting the best results in all studied parameters. Therefore, the dose–response curve for the effects of SeNPs in our study seems to be bell-shaped. Animal studies reported the occurrence of cytotoxicity with high doses of SeNPs and attributed such toxicity to their capability of inducing pro-oxidant effects and DNA damage [100]. This explains why the 5 mg/kg dose could not improve most of the studied parameters and even worsened some of them, such as the appearance of necrotic areas in the histological sections of the prefrontal cortex.
Conclusion
To the best of our knowledge, the present study reported for the first time the neuroprotective role of SeNPs at a dose of 2.5 mg/kg in improving behavioral performance, prefrontal cortical and hippocampal serotonin level and histological architecture in rat model of CRS through their anti-oxidant, anti-inflammatory and anti-apoptotic effects. Finally, SeNPs appear to be a new promising pharmacological tool in protecting against the detrimental effects of chronic stress on the brain. The pharmacodynamics and toxicity of SeNPs on different organs need to be studied. The effect of SeNPs on brain neurogenesis and synaptogenesis in CRS need to be investigated as well.
Data Availability
Data of this study are available from the corresponding author upon request.
Abbreviations
- BAX:
-
Bcl-2-associated protein X
- CRS:
-
Chronic restraint stress
- DLS:
-
Dynamic light scattering
- GPx:
-
Glutathione peroxidase
- GSH:
-
Reduced glutathione
- H&E:
-
Hematoxylin and eosin
- HP:
-
Hippocampus
- HPA:
-
Hypothalamic pituitary adreno-cortical axis
- KF-κβ:
-
Nuclear factor kappa beta
- MAPK:
-
Mitogen activated protein kinase
- MDA:
-
Malondialdehyde
- PDI:
-
Polydispersity index
- PFC:
-
Prefrontal cortex
- ROS:
-
Reactive oxygen species
- SeNPs:
-
Selenium nanoparticles
- TEM:
-
Transmission electron microscope
- TNF-α:
-
Tumor necrosis factor alpha
References
Becerril-Chávez H, Colín-González AL, Villeda-Hernández J, Galván-Arzate S, Chavarría A, de Lima ME, Túnez I, Santamaría A (2017) Protective effects of S-allyl cysteine on behavioral, morphological and biochemical alterations in rats subjected to chronic restraint stress: antioxidant and anxiolytic effects. J Funct Foods 35:105–114. https://doi.org/10.1016/j.jff.2017.05.034
Hegab II, Baarhoma RA, Abd El-Latif RN, El-Esawy R (2019) The prospective protective effect of selenium against chronic restraint stress-induced memory impairment in male albino rats. Med J Cairo Univ 87:1563–1572. https://doi.org/10.21608/mjcu.2019.53576
Alkadhi K (2013) Brain physiology and pathophysiology in mental stress. ISRN 2013. https://doi.org/10.1155/2013/806104
Chu B, Marwaha K, Sanvictores T, Ayers D (2021) Physiology, stress reaction. StatPearls Publishing Treasure Island (FL). https://www.ncbi.nlm.nih.gov/books/NBK541120/. Accessed 30 September 2021
Phyu P, Dumenigo R, Oms JD, Gunaseelan L, Foroughi G, Rizvi SAA (2017) The influence of chronic stress on the development of psychiatric conditions. Consultant 57:76–83. https://doi.org/10.1017/S1092852918000585
Juszczyk G, Mikulska J, Kasperek K, Pietrzak D, Mrozek W, Herbet M (2021) Chronic stress and oxidative stress as common factors of the pathogenesis of depression and Alzheimer’s disease: The role of antioxidants in prevention and treatment. Antioxidants 10(9):1439. https://doi.org/10.3390/antiox10091439
Salim S (2017) Oxidative stress and the central nervous system. J Pharmacol Exp Ther 360(1):201–205. https://doi.org/10.1124/jpet.116.237503
Tang VM (2012) Glucocorticoid effects on oxidative stress and mitochondrial dysfunction. Dissertation, University of British Columbia. https://doi.org/10.14288/1.0072794
Calcia MA, Bonsall DR, Bloomfield PS, Selvaraj S, Barichello T, Howes OD (2016) Stress and neuroinflammation: a systematic review of the effects of stress on microglia and the implications for mental illness. Psychopharmacology 233(9):1637–1650. https://doi.org/10.1007/s00213-016-4218-9
Wu T, Li X, Li T, Cai M, Yu Z, Zhang J, Zhang Z, Zhang W, Xiang J, Cai D (2018) Apocynum venetum leaf extract exerts antidepressant-like effects and inhibits hippocampal and cortical apoptosis of rats exposed to chronic unpredictable mild stress. Evid Based Complement Alternat Med 2018. https://doi.org/10.1155/2018/5916451
Puglisi-Allegra S, Andolina D (2015) Serotonin and stress coping. Behav Brain Res 277:58–67. https://doi.org/10.1016/j.bbr.2014.07.052
Becker M, Pinhasov A, Ornoy A (2021) Animal models of depression: what can they teach us about the human disease? Diagnostics 11(1):123. https://doi.org/10.3390/diagnostics11010123
Wang Q, Timberlake MA, Prall K, Dwivedi Y (2017) The recent progress in animal models of depression. Prog Neuropsychopharmacol Biol Psychiatry 77:99–109. https://doi.org/10.1016/j.pnpbp.2017.04.008
Patra JK, Das G, Fraceto LF, Campos EVR, Rodriguez-Torres MdP, Acosta-Torres LS, Diaz-Torres LA, Grillo R et al (2018) Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol 16(1):71. https://doi.org/10.1186/s12951-018-0392-8
Hami Z (2021) A brief review on advantages of nano-based drug delivery systems. Ann Mil Health Sci Res 19(1):e112274. https://doi.org/10.5812/amh.112274
Hosnedlova B, Kepinska M, Skalickova S, Fernandez C, Ruttkay-Nedecky B, Peng Q, Baron M, Melcova M et al (2018) Nano-selenium and its nanomedicine applications: a critical review. Int J Nanomedicine 13:2107–2128. https://doi.org/10.2147/ijn.S157541
Khurana A, Tekula S, Saifi MA, Venkatesh P, Godugu C (2019) Therapeutic applications of selenium nanoparticles. Biomed Pharmacother 111:802–812. https://doi.org/10.1016/j.biopha.2018.12.146
Nie T, Wu H, Wong KH, Chen T (2016) Facile synthesis of highly uniform selenium nanoparticles using glucose as the reductant and surface decorator to induce cancer cell apoptosis. J Mater Chem B 4(13):2351–2358. https://doi.org/10.1039/C5TB02710A
Hegazy MA, Maklad HM, Samy DM, Abdelmonsif DA, El Sabaa BM, Elnozahy FY (2017) Cerium oxide nanoparticles could ameliorate behavioral and neurochemical impairments in 6-hydroxydopamine induced Parkinson’s disease in rats. Neurochem Int 108:361–371. https://doi.org/10.1016/j.neuint.2017.05.011
Nade VS, Yadav AV (2010) Anti-stress effect of ethyl acetate soluble fraction of Morus alba in chronic restraint stress. Pharm Biol 48(9):1038–1046. https://doi.org/10.3109/13880200903473741
Ning J, Jing-Wei L, Hai-Xia W, Hong H, Qiong W, Shan-Guang C, Li-Na Q, Dias ACP et al (2019) Antidepressant-like effects of ginsenoside Rg1 in the chronic restraint stress-induced rat model. Digit Chin Med 2(4):207–218. https://doi.org/10.1016/j.dcmed.2020.01.002
Chandramohan S, Naveenkumar S, Kaviyarasu K, Lavakumar V, Sowmya C, Santhanakumar M, Muthukumaran A (2021) Bio-distribution of selenium nanoparticles (SeNPs) to the Wistar rats and its breastfed offspring. J Drug Deliv Sci Technol 61(5):102299. https://doi.org/10.1016/j.jddst.2020.102299
Jangra A, Sriram CS, Dwivedi S, Gurjar SS, Hussain MI, Borah P, Lahkar M (2017) Sodium phenylbutyrate and edaravone abrogate chronic restraint stress-induced behavioral deficits: implication of oxido-nitrosative, endoplasmic reticulum stress cascade, and neuroinflammation. Cell Mol Neurobiol 37(1):65–81. https://doi.org/10.1007/s10571-016-0344-5
Yang Y, Hu Z, Du X, Davies H, Huo X, Fang M (2017) miR-16 and fluoxetine both reverse autophagic and apoptotic change in chronic unpredictable mild stress model rats. Front Neurosci 11:428. https://doi.org/10.3389/fnins.2017.00428
Shen M, Yang Y, Wu Y, Zhang B, Wu H, Wang L, Tang H, Chen J (2019) L-theanine ameliorate depressive-like behavior in a chronic unpredictable mild stress rat model via modulating the monoamine levels in limbic-cortical-striatal-pallidal-thalamic-circuit related brain regions. Phytother Res 33(2):412–421. https://doi.org/10.1002/ptr.6237
Zhuang PC, Tan ZN, Jia ZY, Wang B, Grady JJ, Ma XM (2019) Treadmill exercise reverses depression model-induced alteration of dendritic spines in the brain areas of mood circuit. Front Behav Neurosci 13:93. https://doi.org/10.3389/fnbeh.2019.00093
Mao Y, Xu Y, Yuan X (2022) Validity of chronic restraint stress for modeling anhedonic-like behavior in rodents: a systematic review and meta-analysis. J Int Med Res 50(2):1–26. https://doi.org/10.1177/03000605221075816
Zhou H, Tan H, Letourneau L, Wang JF (2019) Increased thioredoxin-interacting protein in brain of mice exposed to chronic stress. Prog Neuropsychopharmacol Biol Psychiatry 88:320–326. https://doi.org/10.1016/j.pnpbp.2018.08.013
Xu L, Shao A, Zhao Y, Wang Z, Zhang C, Sun Y, Deng J, Chou LL (2015) Neurotoxicity of silver nanoparticles in rat brain after intragastric exposure. J Nanosci Nanotechnol 15(6):4215–4223. https://doi.org/10.1166/jnn.2015.9612
Thomas J, Khanam R, Vohora D (2015) A validated HPLC-UV method and optimization of sample preparation technique for norepinephrine and serotonin in mouse brain. Pharm Biol 53(10):1539–1544. https://doi.org/10.3109/13880209.2014.991837
De Benedetto GE, Fico D, Pennetta A, Malitesta C, Nicolardi G, Lofrumento DD, De Nuccio F, La Pesa V (2014) A rapid and simple method for the determination of 3,4-dihydroxyphenylacetic acid, norepinephrine, dopamine, and serotonin in mouse brain homogenate by HPLC with fluorimetric detection. J Pharm Biomed Anal 98:266–270. https://doi.org/10.1016/j.jpba.2014.05.039
Badawy S, Hammad S, Amine S, El-Seidy A, Abdou Slima S (2017) Biochemical and histopathological changes in the brain of albino rats treated with profenofos and the possible protective effect of vitamins C and E. Menoufia Med J 30(1):278–285. https://doi.org/10.4103/mmj.mmj_476_16
Liu L, Zhou X, Zhang Y, Liu Y, Yang L, Pu J, Zhu D, Zhou C et al (2016) The identification of metabolic disturbances in the prefrontal cortex of the chronic restraint stress rat model of depression. Behav Brain Res 305:148–156. https://doi.org/10.1016/j.bbr.2016.03.005
Aboul-Fotouh S (2015) Behavioral effects of nicotinic antagonist mecamylamine in a rat model of depression: prefrontal cortex level of BDNF protein and monoaminergic neurotransmitters. Psychopharmacology 232(6):1095–1105. https://doi.org/10.1007/s00213-014-3745-5
Liang S, Wang T, Hu X, Luo J, Li W, Wu X, Duan Y, Jin F (2015) Administration of Lactobacillus helveticus NS8 improves behavioral, cognitive, and biochemical aberrations caused by chronic restraint stress. Neuroscience 310:561–577. https://doi.org/10.1016/j.neuroscience.2015.09.033
Naert G, Ixart G, Maurice T, Tapia-Arancibia L, Givalois L (2011) Brain-derived neurotrophic factor and hypothalamic-pituitary-adrenal axis adaptation processes in a depressive-like state induced by chronic restraint stress. Mol Cell Neurosci 46(1):55–66. https://doi.org/10.1016/j.mcn.2010.08.006
Liu B, Zhao L, Yue C, Qian M, Xie M (2019) Changes in gonadal function at different stages of chronic restraint stress-induced depression animals. Physiol Behav 210:112656. https://doi.org/10.1016/j.physbeh.2019.112656
Xu G, Li Y, Ma C, Wang C, Sun Z, Shen Y, Liu L, Li S et al (2019) Restraint stress induced hyperpermeability and damage of the blood-brain barrier in the amygdala of adult rats. Front Mol Neurosci 12:32. https://doi.org/10.3389/fnmol.2019.00032
Bagheri Y, Fathi E, Maghoul A, Moshtagh S, Mokhtari K, Abdollahpour A, Montazersaheb S, Bagheri A (2021) Effects of Achillea tenuifolia Lam. hydro-alcoholic extract on anxiety-like behavior and reproductive parameters in rat model of chronic restraint stress. Hum Exp Toxicol 40(11):1852–1866. https://doi.org/10.1177/09603271211026723
Sántha P, Veszelka S, Hoyk Z, Mészáros M, Walter FR, Tóth AE, Kiss L, Kincses A et al (2015) Restraint stress-induced morphological changes at the blood-brain barrier in adult rats. Front Mol Neurosci 8:88. https://doi.org/10.3389/fnmol.2015.00088
Ayatollahi S, Khoshsirat S, Peyvandi A, Rezaei O, Mehrjardi F, Nahavandi A, Niknazar S (2020) Ginkgo biloba modulates hippocampal BDNF expression in a rat model of chronic restraint stress-induced depression. Physiol Pharmacol 24:285–297. https://doi.org/10.32598/ppj.24.4.20
Guedri K, Frih H, Chettoum A, Rouabhi R (2017) Chronic restraint stress induced neurobehavioral alterations and histological changes in rat. Toxicol Environ Health Sci 9(2):123–129. https://doi.org/10.1007/s13530-017-0312-6
Luo YW, Xu Y, Cao WY, Zhong XL, Duan J, Wang XQ, Hu ZL, Li F et al (2015) Insulin-like growth factor 2 mitigates depressive behavior in a rat model of chronic stress. Neuropharmacology 89:318–324. https://doi.org/10.1016/j.neuropharm.2014.10.011
Peng G, Yang L, Wu CY, Zhang LL, Wu CY, Li F, Shi HW, Hou J et al (2021) Whole body vibration training improves depression-like behaviors in a rat chronic restraint stress model. Neurochem Int 142:104926. https://doi.org/10.1016/j.neuint.2020.104926
García-Rojo G, Fresno C, Vilches N, Díaz-Véliz G, Mora S, Aguayo F, Pacheco A, Parra-Fiedler N et al (2017) The ROCK inhibitor fasudil prevents chronic restraint stress-induced depressive-like behaviors and dendritic spine loss in rat hippocampus. Int J Neuropsychopharmacol 20(4):336–345. https://doi.org/10.1093/ijnp/pyw108
Grundmann O, Lv Y, Kelber O, Butterweck V (2010) Mechanism of St. John’s wort extract (STW3-VI) during chronic restraint stress is mediated by the interrelationship of the immune, oxidative defense, and neuroendocrine system. Neuropharmacology 58(4):767–773. https://doi.org/10.1016/j.neuropharm.2009.12.014
Suwanjang W, Ruankham W, Chetsawang B, Mukda S, Ngampramuan S, Srisung S, Prachayasittikul V, Prachayasittikul S (2021) Spilanthes acmella Murr ameliorates chronic stress through improving mitochondrial function in chronic restraint stress rats. Neurochem Int 148:105083. https://doi.org/10.1016/j.neuint.2021.105083
Adachi N, Sakhri FZ, Ikemoto H, Ohashi Y, Kato M, Inoue T, Hisamitsu T, Sunagawa M (2022) Kamikihito rescued depressive-like behaviors and hippocampus neurogenesis in chronic restraint stress rats. J Tradit Complement Med 12(2):172–179. https://doi.org/10.1016/j.jtcme.2021.08.001
Al-Quraishy S, Dkhil MA, Abdel Moneim AE (2015) Anti-hyperglycemic activity of selenium nanoparticles in streptozotocin-induced diabetic rats. Int J Nanomedicine 10:6741–6756. https://doi.org/10.2147/ijn.S91377
Gong T, Torres DJ, Berry MJ, Pitts MW (2018) Hypothalamic redox balance and leptin signaling-emerging role of selenoproteins. Free Radic Biol Med 127:172–181. https://doi.org/10.1016/j.freeradbiomed.2018.02.038
Fontella FU, Siqueira IR, Vasconcellos APS, Tabajara AS, Netto CA, Dalmaz C (2005) Repeated restraint stress induces oxidative damage in rat hippocampus. Neurochem Res 30(1):105–111. https://doi.org/10.1007/s11064-004-9691-6
Lin S, Li Q, Jiang S, Xu Z, Jiang Y, Liu L, Jiang J, Tong Y et al (2021) Crocetin ameliorates chronic restraint stress-induced depression-like behaviors in mice by regulating MEK/ERK pathways and gut microbiota. J Ethnopharmacol 268:113608. https://doi.org/10.1016/j.jep.2020.113608
Spiers JG, Chen HJ, Sernia C, Lavidis NA (2014) Activation of the hypothalamic-pituitary-adrenal stress axis induces cellular oxidative stress. Front Neurosci 8:456. https://doi.org/10.3389/fnins.2014.00456
Banagozar Mohammadi A, Torbati M, Farajdokht F, Sadigh-Eteghad S, Fazljou SMB, Vatandoust SM, Golzari SEJ, Mahmoudi J (2019) Sericin alleviates restraint stress induced depressive- and anxiety-like behaviors via modulation of oxidative stress, neuroinflammation and apoptosis in the prefrontal cortex and hippocampus. Brain Res 1715:47–56. https://doi.org/10.1016/j.brainres.2019.03.020
Novaes LS, Dos Santos NB, Dragunas G, Perfetto JG, Leza JC, Scavone C, Munhoz CD (2018) Repeated restraint stress decreases Na, K-ATPase activity via oxidative and nitrosative damage in the frontal cortex of rats. Neuroscience 393:273–283. https://doi.org/10.1016/j.neuroscience.2018.09.037
Pezeshki-Nia S, Asle-Rousta M, Mahmazi S (2020) Spinacia oleracea L. extract attenuates hippocampal expression of TNF-α and IL-1β in rats exposed to chronic restraint stress. Med J Islam Repub Iran 34:10. https://doi.org/10.34171/mjiri.34.10
Nouri M, Farajdokht F, Torbati M, Ranjbar F, Hamedyazdan S, Sadigh-Eteghad S, Araj-Khodaei M (2019) Antidepressant and anxiolytic effect of echium amoenum in restraint stress model: the role of neuroinflammation in the prefrontal cortex and hippocampus. Iran Red Crescent Med J 21(10):e95438. https://doi.org/10.5812/ircmj.95438
Kuswati K (2015) The effect of centella asiatica ethanolic extract on caspase-3 expression in prefrontal cortex of chronic restraint stress induced sprague dawley rat. Jurnal Kedokteran dan Kesehatan Indonesia 7:65–72. https://doi.org/10.20885/JKKI.Vol7.Iss2.art6
Orlovsky MA, Dosenko VE, Spiga F, Skibo GG, Lightman SL (2014) Hippocampus remodeling by chronic stress accompanied by GR, proteasome and caspase-3 overexpression. Brain Res 1593:83–94. https://doi.org/10.1016/j.brainres.2014.09.059
Seo H, Park C-H, Choi S, Kim W, Jeon B-D, Ryu S (2016) Effects of voluntary exercise on apoptosis and cortisol after chronic restraint stress in mice. J Exerc Nutr Biochem 20(3):16–23. https://doi.org/10.20463/jenb.2016.09.20.3.3
Tian R, Hou G, Li D, Yuan TF (2014) A possible change process of inflammatory cytokines in the prolonged chronic stress and its ultimate implications for health. Sci World J 2014:780616. https://doi.org/10.1155/2014/780616
Liu YZ, Wang YX, Jiang CL (2017) Inflammation: The common pathway of stress-related diseases. Front Hum Neurosci 11:316. https://doi.org/10.3389/fnhum.2017.00316
Solleiro-Villavicencio H, Rivas-Arancibia S (2018) Effect of chronic oxidative stress on neuroinflammatory response mediated by CD4(+)T cells in neurodegenerative diseases. Front Cell Neurosci 12:114. https://doi.org/10.3389/fncel.2018.00114
Redza-Dutordoir M, Averill-Bates DA (2016) Activation of apoptosis signalling pathways by reactive oxygen species. Biochim Biophys Acta 1863(12):2977–2992. https://doi.org/10.1016/j.bbamcr.2016.09.012
Dionisie V, Ciobanu AM, Toma VA, Manea MC, Baldea I, Olteanu D, Sevastre-Berghian A, Clichici S et al (2021) Escitalopram targets oxidative Stress, caspase-3, BDNF and MeCP2 in the hippocampus and frontal cortex of a rat model of depression induced by chronic unpredictable mild stress. Int J Mol Sci 22(14):7483. https://doi.org/10.3390/ijms22147483
Duman RS (2009) Neuronal damage and protection in the pathophysiology and treatment of psychiatric illness: stress and depression. Dialogues Clin Neurosci 11(3):239–255. https://doi.org/10.31887/DCNS.2009.11.3/rsduman
Bashir DW, Rashad MM, Ahmed YH, Drweesh EA, Elzahany EAM, Abou-El-Sherbini KS, El-Leithy EMM (2021) The ameliorative effect of nanoselenium on histopathological and biochemical alterations induced by melamine toxicity on the brain of adult male albino rats. Neurotoxicology 86:37–51. https://doi.org/10.1016/j.neuro.2021.06.006
Mohammed ET, Safwat GM (2013) Assessment of the ameliorative role of selenium nanoparticles on the oxidative stress of acetaminophen in some tissues of male albino rats. Beni-Suef Uni J Basic Appl Sci 2(2):80–85. https://doi.org/10.1016/j.bjbas.2013.01.003
Ebokaiwe AP, Okori S, Nwankwo JO, Ejike C, Osawe SO (2021) Selenium nanoparticles and metformin ameliorate streptozotocin-instigated brain oxidative-inflammatory stress and neurobehavioral alterations in rats. Naunyn Schmiedebergs Arch Pharmacol 394(4):591–602. https://doi.org/10.1007/s00210-020-02000-2
Yuan X, Fu Z, Ji P, Guo L, Al-Ghamdy AO, Alkandiri A, Habotta OA, Abdel Moneim AE et al (2020) Selenium nanoparticles pre-treatment reverse behavioral, oxidative damage, neuronal loss and neurochemical alterations in pentylenetetrazole-induced epileptic seizures in mice. Int J Nanomedicine 15:6339–6353. https://doi.org/10.2147/ijn.S259134
Ali HFH, El-Sayed NM, Khodeer DM, Ahmed AAM, Hanna PA, Moustafa YMA (2020) Nano selenium ameliorates oxidative stress and inflammatory response associated with cypermethrin-induced neurotoxicity in rats. Ecotoxicol Environ Saf 195:110479. https://doi.org/10.1016/j.ecoenv.2020.110479
Al Kahtani MA (2020) Effect of both selenium and biosynthesized nanoselenium particles on cadmium-induced neurotoxicity in albino rats. Hum Exp Toxicol 39(2):159–172. https://doi.org/10.1177/0960327119880589
Yue D, Zeng C, Okyere SK, Chen Z, Hu Y (2021) Glycine nano-selenium prevents brain oxidative stress and neurobehavioral abnormalities caused by MPTP in rats. J Trace Elem Med Biol 64:126680. https://doi.org/10.1016/j.jtemb.2020.126680
Yang L, Wang W, Chen J, Wang N, Zheng G (2018) A comparative study of resveratrol and resveratrol-functional selenium nanoparticles: Inhibiting amyloid β aggregation and reactive oxygen species formation properties. J Biomed Mater Res A 106(12):3034–3041. https://doi.org/10.1002/jbm.a.36493
Gao F, Zhao J, Liu P, Ji D, Zhang L, Zhang M, Li Y, Xiao Y (2020) Preparation and in vitro evaluation of multi-target-directed selenium-chondroitin sulfate nanoparticles in protecting against the Alzheimer’s disease. Int J Biol Macromol 142:265–276. https://doi.org/10.1016/j.ijbiomac.2019.09.098
Zhang ZH, Song GL (2021) Roles of selenoproteins in brain function and the potential mechanism of selenium in Alzheimer’s disease. Front Neurosci 15:646518. https://doi.org/10.3389/fnins.2021.646518
Jolly J, Ahmar R, Zeeshan A (2020) Selenium nanoparticles: Small is the new big: Mini review. Open J Chem 6(1):013–016. https://doi.org/10.17352/ojc.000018
Wang J, Cheng C, Xin C, Wang Z (2019) The antidepressant-like effect of flavonoids from Trigonella foenum-graecum seeds in chronic restraint stress mice via modulation of monoamine regulatory pathways. Molecules 24(6):1105. https://doi.org/10.3390/molecules24061105
Sunanda RBSS, Raju TR (2000) Restraint stress-induced alterations in the levels of biogenic amines, amino acids, and AChE activity in the hippocampus. Neurochem Res 25(12):1547–1552. https://doi.org/10.1023/A:1026606201069
Liu B, Liu J, Wang M, Zhang Y, Li L (2017) From serotonin to neuroplasticity: evolvement of theories for major depressive disorder. Front Cell Neurosci 11:305. https://doi.org/10.3389/fncel.2017.00305
Höglund E, Øverli Ø, Winberg S (2019) Tryptophan metabolic pathways and brain serotonergic activity: a comparative review. Front Endocrinol 10:158. https://doi.org/10.3389/fendo.2019.00158
Jeon SW, Kim YK (2018) The role of neuroinflammation and neurovascular dysfunction in major depressive disorder. J Inflamm Res 11:179–192. https://doi.org/10.2147/jir.S141033
Rahman MS, Thomas P (2014) Restoration of tryptophan hydroxylase functions and serotonin content in the Atlantic croaker hypothalamus by antioxidant treatment during hypoxic stress. Front Neurosci 8:1–13. https://doi.org/10.3389/fnins.2014.00130
Abou Zaid OAR, El-Sonbaty SM, Barakat WM (2017) Effect of acrylamide on neurotransmitters and acetyl-cholinestrase activity in the brain of rats : therapeutic effect of ferulic acid and selenium nanoparticles. Ann Brit Med Sci 3(1):18–25
Zhu YL, Wang LY, Zhao DP, Wang CL, Zhang R, Fei WT, Wang JX, Zhang JJ (2020) Antidepressant-like effects of albiflorin involved the NO signaling pathway in rats model of chronic restraint stress. Chin J Nat Med 18(11):872–880. https://doi.org/10.1016/s1875-5364(20)60030-9
Carneiro de Oliveira PE, Zaniboni CR, Carmona IM, Fonseca AR, Canto-de-Souza A (2017) Preliminary behavioral assessment of cagemates living with conspecifics submitted to chronic restraint stress in mice. Neurosci Lett 657:204–210. https://doi.org/10.1016/j.neulet.2017.07.008
Sheng W, Haiping W, Mingqi Q (2012) Behavioral observation and analysis of PMS liver-qi depression rat model established by chronic restraint stress and resident-intruder paradigm. World Sci Technol 14(4):1848–1852. https://doi.org/10.1016/S1876-3553(13)60009-5
Shen J, Lin L, Liao L, Liang W, Yang X, Lin K, Ke L, Zhang L, Kang J, Ding S, Li C, Zheng Z (2020) The involvement of Notch1 signaling pathway in mid-aged female rats under chronic restraint stress. Neurosci Lett 738:1–8. https://doi.org/10.1016/j.neulet.2020.135313
Lee B, Sur B, Park J, Kim S-H, Kwon S, Yeom M, Shim I, Lee H et al (2013) Chronic administration of baicalein decreases depression-like behavior induced by repeated restraint stress in rats. Korean J Physiol Pharmacol 17(5):393–403. https://doi.org/10.4196/kjpp.2013.17.5.393
Khalil HMA, Azouz RA, Hozyen HF, Aljuaydi SH, AbuBakr HO, Emam SR, Al-Mokaddem AK (2022) Selenium nanoparticles impart robust neuroprotection against deltamethrin-induced neurotoxicity in male rats by reversing behavioral alterations, oxidative damage, apoptosis, and neuronal loss. Neurotoxicology 91:329–339. https://doi.org/10.1016/j.neuro.2022.06.006
Salama RM, El-Sherif NM (2018) Ameliorative effect of dark chocolate on brain and heart of chronic restraint stressed male albino rats. Austin J Anat 5(1):1076
Jayakumar S, Raghunath G, Ilango S, Vijayakumar J, Vijayaraghavan R (2017) Effect of fluoxetine on the hippocampus of Wistar albino rats in cold restraint stress model. J Clin Diagn Res 11(6):1–6. https://doi.org/10.7860/jcdr/2017/26958.9953
Feng X, Zhao Y, Yang T, Song M, Wang C, Yao Y, Fan H (2019) Glucocorticoid-driven NLRP3 inflammasome activation in hippocampal microglia mediates chronic stress-induced depressive-like behaviors. Front Mol Neurosci 12:210. https://doi.org/10.3389/fnmol.2019.00210
Chandrasekhar BVS, Elango P, Maheswari SU, Rajukumar D (2017) A focus on the effect of L-theanine on improving depression and cognition in C57BL/J male mice subjected for chronic stress induced neuroinflammation. Biomed Pharmacol J 10(2):1015–1027. https://doi.org/10.13005/bpj/1199
de Lima ME, Ceolin Colpo AZ, Maya-López M, Rangel-López E, Becerril-Chávez H, Galván-Arzate S, Villeda-Hernández J, Sánchez-Chapul L et al (2019) Comparing the effects of chlorogenic acid and Ilex paraguariensis extracts on different markers of brain alterations in rats subjected to chronic restraint stress. Neurotox Res 35(2):373–386. https://doi.org/10.1007/s12640-018-9963-6
McEwen BS, Morrison JH (2013) The brain on stress: vulnerability and plasticity of the prefrontal cortex over the life course. Neuron 79(1):16–29. https://doi.org/10.1016/j.neuron.2013.06.028
Anand KS, Dhikav V (2012) Hippocampus in health and disease: an overview. Ann Indian Acad Neurol 15(4):239–246. https://doi.org/10.4103/0972-2327.104323
Abozaid O (2017) Ameliorative effect of selenium nanoparticles and ferulic acid on acrylamide-induced neurotoxicity in rats. Ann Biomed Sci 3(2):35–45
Ibrahim HM, Zommara MA, Elnaggar ME (2021) Ameliorating effect of selenium nanoparticles on cyclophosphamide-induced hippocampal neurotoxicity in male rats: light, electron microscopic and immunohistochemical study. Folia Morphol (Warsz) 80(4):806–819. https://doi.org/10.5603/FM.a2020.0117
Varlamova EG, Turovsky EA, Blinova EV (2021) Therapeutic potential and main methods of obtaining selenium nanoparticles. Int J Mol Sci 22(19):1–25. https://doi.org/10.3390/ijms221910808
Funding
Open access funding provided by The Science, Technology & Innovation Funding Authority (STDF) in cooperation with The Egyptian Knowledge Bank (EKB). Animals and husbandry were supported by funding from the Physiology Department, Faculty of Medicine, Alexandria University.
Author information
Authors and Affiliations
Contributions
Study conception and design were performed by Sarah A. Elfakharany and Doaa A. Abdelmonsif. Data collection and implementation of the experiment were carried out by Sarah A. Elfakharany, Doaa A. Abdelmonsif and Nesrine M. El Azhary. Analysis and interpretation of results were done by Sarah A. Elfakharany, Nesrine M. El Azhary and Youssef A. Hatem. Histopathological assessment was performed by Teshreen M. Zeitoun and Sarah A. Elfakharany. HPLC assay was done by Gamal A.G. Ammar, Doaa A. Abdelmonsif and Sarah A. Elfakharany. Other biochemical assays were carried out by Doaa A. Abdelmonsif and Sarah A. Elfakharany. The first draft of the manuscript was written and edited by Sarah A. Elfakharany, Nesrine M. El Azhary, Doaa A. Abdelmonsif and Teshreen M. Zeitoun. Youssef A. Hatem and Samir S. Eskaros reviewed the manuscript and approved the final version.
Corresponding author
Ethics declarations
Ethics Approval
The study protocol was approved by the institutional Medical Ethics Committee, Faculty of Medicine (IRB NO: 00012098; FWA NO: 00018699; approval NO: 0106414).
Consent to Participate
Not applicable.
Consent for Publication
Not applicable.
Competing Interests
The authors declare no competing interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
About this article
Cite this article
Elfakharany, S.A., Eskaros, S.S., Azhary, N.M.E. et al. Neuroprotective Role of Selenium Nanoparticles Against Behavioral, Neurobiochemical and Histological Alterations in Rats Subjected to Chronic Restraint Stress. Mol Neurobiol (2024). https://doi.org/10.1007/s12035-024-04196-3
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s12035-024-04196-3